Insider Trading: Furiex Pharmaceuticals Inc (FURX.O)
FURX.O on Nasdaq
39.36USD
24 May 2013
39.36USD
24 May 2013
Price Change (% chg)
$-0.50 (-1.25%)
$-0.50 (-1.25%)
Prev Close
$39.86
$39.86
Open
$39.79
$39.79
Day's High
$40.25
$40.25
Day's Low
$39.04
$39.04
Volume
38,311
38,311
Avg. Vol
80,012
80,012
52-wk High
$42.30
$42.30
52-wk Low
$17.50
$17.50
| ESHELMAN FREDRIC N | Options Exercised: 0 | ||
| Trade Date: | Monday, 12 Mar 2012 | Price: | 23.45 |
| Title: | Director and Beneficial Owner | Shares Held: | 2,289,553 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 45,307 |
Institutional Holders
| % Shares Owned: | 56.42% |
| # of Holders: | 115 |
| Total Shares Held: | 5,706,155 |
| 3 Mo. Net Change: | 373,148 |
| # New Positions: | 27 |
| # Closed Positions: | 9 |
| # Increased Positions: | 57 |
| # Reduced Positions: | 43 |
| # Net Buyers: | 14 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Fredric Eshelman |
63 | 2009 | Chairman of the Board |
June Almenoff |
56 | 2012 | President, Chief Medical Officer, Principal Executive Officer, Director |
Marshall Woodworth |
55 | 2010 | Chief Financial Officer, Treasurer, Assistant Secretary |
Paul Covington |
57 | 2010 | Senior Vice President - Clinical Development and Operations |
Gail McIntyre |
50 | 2010 | Senior Vice President - Research |
Peter Corr |
2010 | Independent Director | |
Wendy Dixon |
56 | 2010 | Independent Director |
Stephen Kaldor |
50 | 2010 | Independent Director |
Robert Ruscher |
52 | 2010 | Independent Director |
Sailash Patel |
Vice President - Strategic Development |

